Shape Security
Appthority
Boundless
CTERA
Dollar Shave Club
Happier
Nest Labs
ADVANCE Medical
Appia
Dynamic Signal
FINsix
Hua Medicine
Klout
Kyruus
Personal Capital
Singly
BillFloat
PowerVision
Redbeacon (Home Depot)
Smartling
Ariosa Diagnostics
CloudFlare
Intuity Medical
Live Gamer
Media6Degrees
Mevion
Phononic Devices
Receptos
SocialShield (Avira)
AppNexus
Aria Systems
Awarepoint
Bizo
Castlight Health
Constellation Pharma
Crunchyroll
eIQnetworks
Fate Therapeutics
Gazelle
IP Commerce
Lavante
Martini Media
Sapphire Energy
SlideShare (LinkedIn)
Tudou (NASDAQ: TUDO)
World Heart (HeartWare)
Zeltiq (NASDAQ: ZLTQ)
Asoka
Atieva
BlogHer
Cerulean Pharma
CoreTrace
Good Technology
QuatRx Pharma
Semtek (VeriFone)
WHERE (eBay)
ADiFY (Cox Enterprises)
Adnexus (Bristol-Myers Squibb)
ApaceWave Technologies
B-hive Networks (VMware)
Boston-Power
ExtendMedia (Cisco)
PEAK Surgical (Medtronic)
Quantenna Communications
Transonic Combustion
Virgin Money
Alimera Sciences (NASDAQ: ALIM)
Ciclon Semiconductor (TI)
Ikaria
INRIX
Jadoo Power
Newport Media
Simple Star (Sonic Solutions)
Acceleron Pharma
Achaogen
BCD (NASDAQ: BCDS)
Celladon Corporation
CodeRyte (3M)
DATAllegro (Microsoft)
Metabolex
Neoconix
P.A. Semi (Apple)
RedSeal Networks
Retail Solutions
Trubion Pharma (NASDAQ: TRBN)
ZoomInfo
Anchor Bay Tech (Silicon Image)
Canesta (Microsoft)
Coley Pharma (Pfizer)
Imperva (NYSE: IMPV)
Intarcia Therapeutics
Sirna Therapeutics (Merck)
AVEO Pharma (NASDAQ: AVEO)
DataPower Technology (IBM)
Ensure Medical (Cordis)
IMlogic (Symantec)
MessageOne (Dell)
NanoGram (Wilson Greatbatch)
P-Cube (Cisco)
Pathwork Diagnostics
Pedestal Software (Altiris)
PGP (Symantec)
Vocera (NYSE: VCRA)
Vontu (Symantec)
WholeSecurity (Symantec)
Atrenta
FutureDial
Infinera (NASDAQ: INFN)
Infinity Pharma (NASDAQ: INFI)
Kineto Wireless
Nanosys
Spotlight Solutions (Oracle)
Vitae Pharma
Endeca Technologies (Oracle)
RelayHealth (McKesson)
Renovis (Evotec)
Syntonix Pharma (Biogen Idec)
Unicru (Kronos)
White Amber (Taleo)
Winery Exchange
XenoPort (NASDAQ: XNPT)
athenahealth (NASDAQ: ATHN)
Fogdog Sports (GSI Commerce)
GENBAND
Imaginova
Ironwood Pharma (NASDAQ: IRWD)
IVS (Abbott Labs)
ZettaCom (IDT)
2Wire (Pace)
Airspan Networks (NASDAQ: AIRN)
Authentica (EMC)
Castle Networks (Siemens)
Illumina (NASDAQ: ILMN)
Installation Software (Macrovision)
Memory Pharma (Roche)
Neoforma (Global HC Exchange)
Niku Corporation (CA Clarity)
Sunesis Pharma (NASDAQ: SNSS)
USInternetworking (AT&T)
CrossWorlds Software (IBM)
DoubleClick (Google)
Highground Systems (Sun Microsystems)
Icagen (Pfizer)
MediaMetrix (ComScore Networks)
Qpass (Amdocs)
Arris Networks (Ascend)
Caliper (NASDAQ: CALP)
Haystack Labs (Network Associates)
NetObjects (IBM)
New Oak (Bay Networks/Nortel)
ORATEC (Smith & Nephew)
Symyx (NASDAQ: SMMX)
WhoWhere? (Lycos)
Award Software (Phoenix Tech)
CardioThoracic (Guidant)
Check Point (NASDAQ: CHKP)
Dfx Interactive (Nvidia)
Digex (Intermedia Communications)
New Era of Networks (Sybase)
Ramp Networks (Nokia)
Sonic Innovations
Triangle Pharma (Gilead)
Idun Pharma (Pfizer)
ThermoSpectra (NYSE: TMO)
Anadys Pharma (NASDAQ: ANDS)
Med Partners (CVS)
Millennium Pharma (Takeda)
Signal Pharmaceuticals (Celgene)
Geron (NASDAQ: GERN)
Polycom (NASDAQ: PLCM)
Vical (NASDAQ: VICL)
EP Technologies (Boston Scientific)
HealthSouth (NYSE: HLS)
Pharmacyclics (NASDAQ: PCYC)
Spyglass (OpenTV)
SUGEN (Pharmacia & Upjohn)
Ligand Pharma (NASDAQ: LGND)
PerSeptive BioSystems (ABI)
Gilead Sciences (NASDAQ: GILD)
American Superconductor (NASDAQ: AMSC)
Mitek Products (Johnson & Johnson)
NovaCare (Select Medical)
TriQuint (NASDAQ: TQNT)
Athena Neurosciences (Elan)
Dianon Systems (LabCorp)
IDEC Pharma (Biogen)
SDRC (UGS)
StrataCom (Cisco)
Kopin (NASDAQ: KOPN)
Sepracor (NASDAQ: SEPR)
IDEXX Labs (NASDAQ: IDXX)
Sierra Semiconductor (PMC-Sierra)
Komag (Western Digital)
Sequent Computer
Cognex (NASDAQ: CGNX)
Liposome (Elan Pharma)
3Com (HP)
Mentor Graphics (NASDAQ: MENT)
Ungermann Bass (Tandem)
Apollo Computer (HP)
California Energy (IPO)
Centocor (Johnson & Johnson)
Genetics Institute (Wyeth)
VLSI Technology (Phillips)
Apple (NASDAQ: AAPL)
E&S (NASDAQ: ESCC)
Intel (NASDAQ: INTC)
Coherent (NASDAQ: COHR)
Thermo Electron (NYSE: TMO)
Mevion Medical Systems, Inc. (formerly Still River Systems, Inc.) is a radiation therapy company dedicated to advancing the treatment of cancer. Mevion’s flagship product, the MEVION S250 Proton Therapy System, is designed to preserve all of the treatment benefits of traditional proton therapy systems while removing the obstacles of size, cost, and complexity. The United States Food and Drug Administration has not cleared the MEVION S250 Proton Therapy System for clinical use.
- Sector: Medical Devices
- Investment Status: Active
- Year Funded: 2009
Venrock Team
Anders HoveMevion Live 
-
Mevion Showcases MEVION S250 Proton Therapy System at ASTRO 2012: http://t.co/9QjPqGTk #protontherapy #cancer
5:01pm December 13th from Mevion Medical -
Mevion's Fifth Proton Accelerator Enters Manufacturing Line at Headquarters http://t.co/BuFPpuCl
10:10am November 2nd from Mevion Medical -
MD Anderson Orlando Breaks Ground on MEVION S250 Proton Therapy Center @orlandohealth #protontherapy #cancer http://t.co/bvAzfwIo
4:28pm September 27th from Mevion Medical -
First Coast Oncology Proton Therapy Center Construction: Time Lapse Video http://t.co/N1FwL2lE via @youtube @Dr_S_Ackerman
10:31am August 27th from Mevion Medical -
Mevion Delivers the MEVION S250 Superconducting Synchrocyclotron to @RWJUH http://t.co/znJzfD2h via @BusinessWire
10:08am July 18th from Mevion Medical -
MEVION S250 accelerator left MA today and is on the way to @RWJUH ! http://t.co/9o8K6WJC
5:17pm July 10th from Mevion Medical -
First Coast Oncology in FL breaks ground for future MEVION S250 Proton Therapy System! http://t.co/WukeZIgl @Dr_S_Ackerman #protontherapy
10:27am June 15th from Mevion Medical -
Mevion Announces FDA 510(k) Clearance for the MEVION S250 Proton Therapy System: http://t.co/9qoR5Sup
10:20am June 11th from Mevion Medical -
Siteman Cancer Center preps proton therapy treatment http://t.co/KgG9k1Ty via @stlbj
1:04pm June 1st from Mevion Medical -
Mevion receives CE Mark for MEVION S250 Proton Therapy System http://t.co/A6Gc39MA
11:13am March 14th from Mevion Medical -
Leading Private Venture Capital Firms Invest $45 Million in Mevion Medical Systems http://t.co/db6GPCUm
5:54pm January 24th from Mevion Medical -
Mevion is Hiring! http://t.co/zrYUYDpH
1:35pm January 17th from Mevion Medical -
Proton accelerator bound for @RWJUH arrived @ our HQ for final integration & testing before shipment later this year! http://t.co/sFyw361e
4:56pm January 11th from Mevion Medical -
Check out this video from UH Seidman Cancer Center in Ohio about their future MEVION S250 installation. http://t.co/K5lUarmU
12:08pm December 28th from Mevion Medical -
http://t.co/VZEvFA4d http://t.co/nrEfMFfe
4:17pm December 7th from Mevion Medical -
Barnes-Jewish gets new machine to treat cancer http://t.co/mu1nAaPq
10:27am November 8th from Mevion Medical -
Proton beam accelerator installation under way | Newsroom | Washington University in St. Lo http://t.co/R2YAtO50
2:11pm November 3rd from Mevion Medical -
I posted 19 photos on Facebook in the album "Mevion Delivers 1st Superconducting Synchrocyclotron" http://t.co/suekj8kc
4:11pm October 31st from Mevion Medical -
Mevion Medical Delivers Superconducting Synchrocyclotron for Proton Therapy to @BarnesJewish http://t.co/Vy5qa6G4 http://t.co/lMVRoWcI
4:06pm October 31st from Mevion Medical
